Cardlytics
CDLX
43 hedge funds and large institutions have $7.92M invested in Cardlytics in 2026 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 27 closing their positions.
406% more call options, than puts
Call options by funds: $4.12M | Put options by funds: $815K
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.49% less ownership
Funds ownership: 31.86% → 30.37% (-1.5%)
27% less funds holding
Funds holding: 59 → 43 (-16)
44% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 16
57% less capital invested
Capital invested by funds: $18.4M → $7.92M (-$10.5M)
59% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
+$411K |
| 2 |
Jane Street
New York
|
+$296K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$214K |
| 4 |
Squarepoint
New York
|
+$202K |
| 5 |
KWM
KMT Wealth Management
El Segundo,
California
|
+$201K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
CAS Investment Partners
Westport,
Connecticut
|
-$365K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$276K |
| 3 |
Vanguard Portfolio Management
Malvern,
Pennsylvania
|
-$181K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$150K |
| 5 |
LPL Financial
San Diego,
California
|
-$133K |
CDLX Hedge Fund Activity: Q2 2026 in Review
43 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q2 2026, worth a combined $7.92M — down 57% from $18.4M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of CDLX and 11 opened new positions — a net loss of 16 holders — while 16 trimmed existing stakes and 9 added.
The largest buyer was 683 Capital Management, adding an estimated $411K. The largest seller was CAS Investment Partners, cutting an estimated $365K.
- 43 institutional investors held Cardlytics (CDLX) as of Q2 2026, down from 59 in Q1 2026.
- Funds reported $7.92M of Cardlytics stock for Q2 2026, down 57% quarter-over-quarter.
- 11 funds opened new Cardlytics positions in Q2 2026 and 27 closed out, a net change of -16 holders.
- The largest Cardlytics buyer in Q2 2026 was 683 Capital Management, an estimated $411K added.
- The largest Cardlytics seller in Q2 2026 was CAS Investment Partners, an estimated $365K sold.
Based on aggregated 13F filings for Q2 2026.